COVID-19 Vaccine Developers Promise Not To Rush Testing
This story is part of Science Friday’s coverage on the novel coronavirus, the agent of the disease COVID-19. Listen to experts discuss the spread, outbreak response, and treatment.
Pharmaceutical companies are racing to find a vaccine for COVID-19. And there is a huge financial incentive to be the first to produce the first vaccine. But as President Donald Trump promises a vaccine “very soon,” nine of the biggest pharma companies signed a letter that pledged not to put profit—or politics—over sound science.
Science writer Maggie Koerth talks about that letter, as well as bad news for a vaccine clinical trial, which paused this week after an unexplained illness in a participant.
Maggie Koerth is a senior science reporter with FiveThirtyEight.com. She’s based in Minneapolis, Minnesota.
The transcript for this segment is being processed. It will be posted within one week after the episode airs.